Prevalence of vertebral fractures and serum sclerostin levels in acromegaly
- 21 May 2021
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 73 (3) , 667-673
Abstract
Objective An increased prevalence of vertebral fractures (VFs) has been reported in previous studies. The aim of this study was to evaluate the association between bone mineral density (BMD), bone turnover markers, serum sclerostin levels, and vertebral fractures (VFs) in acromegaly patients. We also evaluated the effects of gonadal status, disease activity, treatment modality, age, sex, and body mass index (BMI) on skeletal endpoints. Design Case–control study. Patients and measurements Seventy acromegaly patients (M/F:36/34, mean age 45.5 ± 11.9 years) and 70 controls (M/F:31/39; mean age 45.66 ± 11.9 years) were included. VFs, BMD, calcium metabolism, markers of bone turnover, and sclerostin levels were evaluated. BMD was measured by dual-energy X-ray absorptiometry (Hologic QDR 4500). Conventional lateral radiography of the spine was performed and the Genant method was used for the assessment of fractures of T4–L5 vertebrae. Results The prevalence of vertebral fractures was higher in acromegalic patients as compared with the control group (72.9 vs. 20%; p < 0.001). Serum phosphate (P) levels (3.46 ± 0.59 mg/dl vs. 3.11 ± 0.44 mg/dl; p < 0.001) and b-cross laps (CTx) levels (0.47 µg/l, range 0.04–2.38 vs. 0.28 µg/l, range 0.11–0.80; p < 0.001) were significantly higher in acromegaly patients than control subjects. Serum sclerostin levels were similar between either acromegaly patients and control subjects or acromegaly patients with VF and without VF. In the means of treatment modality, VFs were more frequent in patients treated with adjuvant gamma knife radiosurgery (GKS) (p = 0.07). In the binary logistic regression analysis, the age of the acromegaly patients, the presence of hypogonadism, and GKS treatment were the factors significantly correlated with the occurrence of spinal fractures. Conclusions The prevalence of VFs in patients with acromegaly is higher than in control subjects. Since advanced age, the presence of hypogonadism and GKS treatment were the factors predicting VFs in acromegaly; radiological evaluations should be considered as an emerging tool especially in those patients. Although markers of bone turnover elevated in acromegaly, they were not useful for the prediction of fractures. Serum sclerostin levels showed no discrepancy between the two groups and further studies are required for assessment of sclerostin role in this form of secondary osteoporosis.Keywords
All Related Versions
This publication has 23 references indexed in Scilit:
- Romosozumab in Postmenopausal Women with Low Bone Mineral DensityNew England Journal of Medicine, 2014
- Progression of Vertebral Fractures Despite Long-Term Biochemical Control of Acromegaly: A Prospective Follow-up StudyThe Journal of Clinical Endocrinology & Metabolism, 2013
- Vertebral Fractures in Patients With Acromegaly: A 3-Year Prospective StudyThe Journal of Clinical Endocrinology & Metabolism, 2013
- Vertebral Fracture Assessment in AcromegalyJournal of Clinical Densitometry, 2013
- Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent PathwayPLOS ONE, 2011
- High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegalyEuropean Journal of Endocrinology, 2011
- Prevalence of Vertebral Fractures in Men with AcromegalyThe Journal of Clinical Endocrinology & Metabolism, 2008
- Growth Hormone, Insulin-Like Growth Factors, and the SkeletonEndocrine Reviews, 2008
- Increased Prevalence of Radiological Spinal Deformities in Active Acromegaly: A Cross-Sectional Study in Postmenopausal WomenJournal of Bone and Mineral Research, 2005
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993